Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.

Chacko AD, McDade SS, Chanduloy S, Church SW, Kennedy R, Price J, Hall PA, Russell SE.

Cell Oncol (Dordr). 2012 Apr;35(2):85-93. doi: 10.1007/s13402-011-0066-0. Epub 2012 Jan 26.

PMID:
22278362
2.

Benzothiazole bipyridine complexes of ruthenium(II) with cytotoxic activity.

Spillane CB, Fletcher NC, Rountree SM, van den Berg H, Chanduloy S, Morgan JL, Keene FR.

J Biol Inorg Chem. 2007 Aug;12(6):797-807. Epub 2007 May 26.

PMID:
17530304
3.

Altered expression of the septin gene, SEPT9, in ovarian neoplasia.

Burrows JF, Chanduloy S, McIlhatton MA, Nagar H, Yeates K, Donaghy P, Price J, Godwin AK, Johnston PG, Russell SE.

J Pathol. 2003 Dec;201(4):581-8.

PMID:
14648661
4.

Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3.

McIlhatton MA, Burrows JF, Donaghy PG, Chanduloy S, Johnston PG, Russell SE.

Oncogene. 2001 Sep 13;20(41):5930-9.

5.

Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors.

Russell SE, McIlhatton MA, Burrows JF, Donaghy PG, Chanduloy S, Petty EM, Kalikin LM, Church SW, McIlroy S, Harkin DP, Keilty GW, Cranston AN, Weissenbach J, Hickey I, Johnston PG.

Cancer Res. 2000 Sep 1;60(17):4729-34.

Supplemental Content

Loading ...
Support Center